Details for New Drug Application (NDA): 020011
✉ Email this page to a colleague
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 020011
Tradename: | LUPRON DEPOT |
Applicant: | Abbvie Endocrine Inc |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020011
Suppliers and Packaging for NDA: 020011
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011 | NDA | AbbVie Inc. | 0074-3641 | 0074-3641-03 | 1 KIT in 1 CARTON (0074-3641-03) * 1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
LUPRON DEPOT | leuprolide acetate | INJECTABLE;INJECTION | 020011 | NDA | AbbVie Inc. | 0074-3641 | 0074-3641-71 | 1 KIT in 1 CARTON (0074-3641-71) * 1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 22, 1990 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 3.75MG | ||||
Approval Date: | Oct 26, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 020011
Complete Access Available with Subscription